The recent surge in shares of Hims & Hers Health (NYSE: HIMS) has outpaced both peers and broader market benchmarks. For comparison, Teladoc Health is down nearly 9%, Amwell has slid more than 14%, and the S&P 500 has gained just under 21%.
That kind of outperformance raises an obvious question: is the momentum sustainable?
What Is Hims & Hers?
Hims & Hers Health is a digital health and wellness platform built on a straightforward idea: cut out the middleman.
By connecting patients directly with licensed providers online and shipping treatments straight to their doors, the company removes much of the hassle and cost of traditional healthcare systems.
This direct-to-consumer approach has proven highly effective, especially among younger customers who tend to prefer more private, telehealth services.
Growth Is Hitting Its Stride
Second-quarter results gave bulls plenty to cheer about. Revenues and earnings exceeded expectations, driven by a sharp increase in subscribers and higher monthly revenue per user.
The company also delivered operating margin expansion, a sign that its digital-first model is scaling efficiently.
Hims & Hers is guiding for full-year 2025 revenue of $2.3–$2.4 billion, a massive 56–63% jump from 2024. That outlook suggests management is confident in the durability of subscriber growth, engagement, and conversion.
Expanding Beyond the U.S.
A big part of the HIMS story is international growth. The company’s acquisition of ZAVA, a European digital health platform, accelerates its entry into the U.K., Germany, France, and Ireland.
With 1.3 million active ZAVA customers and millions of completed consultations, Hims & Hers is positioning itself to capture share in large, underserved markets while leveraging its existing digital infrastructure.
Betting on AI and Personalized Care
Hims & Hers is also putting serious capital behind technology. Its $870 million convertible note offering will fuel acquisitions, global rollouts, and AI-driven personalization. The recent hiring of Mo Elshenawy as CTO—an executive with deep expertise in AI and large-scale systems—signals that management sees digital innovation as central to its competitive edge.
This focus could allow HIMS to deliver standardized, yet personalized care at scale—an approach investors should be watching closely.
German 
English